RedHill Biopharma Ltd (RDHL):企業の財務・戦略的SWOT分析

◆英語タイトル:RedHill Biopharma Ltd (RDHL) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH246971FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

RedHill Biopharma Ltd (RDHL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

RedHill Biopharma Ltd (RedHill) is a specialty biopharmaceutical company that develops and commercializes therapeutics for gastrointestinal (GI) diseases and cancer. The company’s commercial product portfolio consists of branded prescription drugs including a combination of omeprazole, amoxicillin and rifabutinomeprazole; naloxegol; and rifamycin. It is investigating its pipeline candidates for the treatment of crohn’s disease, non-tuberculous mycobacterial infection (NTM) infections, gastroenteritis, gastritis, irritable bowel syndrome with diarrhea (IBS-D), bowel cleanser, cancer, and novel corona virus disease (COVID-19). The company has a subsidiary in the US. RedHill is headquartered in Tel Aviv, Israel.

RedHill Biopharma Ltd Key Recent Developments

Nov 12,2020: RedHill Biopharma provides q3/2020 results and highlights, including 300% talicia prescription growth
Aug 13,2020: RedHill Biopharma provides Q2/2020 financial results and operational highlights
Jul 01,2020: RedHill Biopharma to present at the Sachs Novel Coronavirus Investment Forum
May 27,2020: RedHill Biopharma provides Q1/2020 financial results and recent highlights including initial Movantik revenues
Apr 21,2020: RedHill Biopharma partners with NIAID for potential Covid-19 drug

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
RedHill Biopharma Ltd – Key Facts
RedHill Biopharma Ltd – Key Employees
RedHill Biopharma Ltd – Key Employee Biographies
RedHill Biopharma Ltd – Major Products and Services
RedHill Biopharma Ltd – History
RedHill Biopharma Ltd – Company Statement
RedHill Biopharma Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
RedHill Biopharma Ltd – Business Description
Product Category: Commercialization of Products
Performance
Product Category: Promotional Services
Performance
R&D Overview
RedHill Biopharma Ltd – Corporate Strategy
RedHill Biopharma Ltd – SWOT Analysis
SWOT Analysis – Overview
RedHill Biopharma Ltd – Strengths
RedHill Biopharma Ltd – Weaknesses
RedHill Biopharma Ltd – Opportunities
RedHill Biopharma Ltd – Threats
RedHill Biopharma Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
RedHill Biopharma Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 12, 2020: RedHill Biopharma provides q3/2020 results and highlights, including 300% talicia prescription growth
Aug 13, 2020: RedHill Biopharma provides Q2/2020 financial results and operational highlights
Jul 01, 2020: RedHill Biopharma to present at the Sachs Novel Coronavirus Investment Forum
May 27, 2020: RedHill Biopharma provides Q1/2020 financial results and recent highlights including initial Movantik revenues
Apr 21, 2020: RedHill Biopharma partners with NIAID for potential Covid-19 drug
Mar 25, 2020: RedHill Biopharma provides business update
Mar 04, 2020: RedHill Biopharma provides full-year 2019 financial results and operational highlights
Feb 25, 2020: AstraZeneca licences Movantik to RedHill Biopharma
Feb 25, 2020: RedHill Biopharma enters $115 Million non-dilutive financing agreement with HealthCare Royalty Partners
Jan 02, 2020: RedHill Biopharma regains rights to its proprietary bowel preparation RHB-106
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
RedHill Biopharma Ltd, Key Facts
RedHill Biopharma Ltd, Key Employees
RedHill Biopharma Ltd, Key Employee Biographies
RedHill Biopharma Ltd, Major Products and Services
RedHill Biopharma Ltd, History
RedHill Biopharma Ltd, Subsidiaries
RedHill Biopharma Ltd, Key Competitors
RedHill Biopharma Ltd, Ratios based on current share price
RedHill Biopharma Ltd, Annual Ratios
RedHill Biopharma Ltd, Annual Ratios (Cont...1)
RedHill Biopharma Ltd, Interim Ratios
RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
RedHill Biopharma Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[RedHill Biopharma Ltd (RDHL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Valentino Fashion Group S.p.A:企業の戦略・SWOT・財務情報
    Valentino Fashion Group S.p.A - Strategy, SWOT and Corporate Finance Report Summary Valentino Fashion Group S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • The Walsh Group:企業の戦略的SWOT分析
    The Walsh Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Daito Trust Construction Co., Ltd.:企業の戦略・SWOT・財務情報
    Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Metso Corporation:企業の戦略・SWOT・財務情報
    Metso Corporation - Strategy, SWOT and Corporate Finance Report Summary Metso Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Shenzhen Neptunus Interlong Bio-Technique Co Ltd (8329):企業の財務・戦略的SWOT分析
    Summary Shenzhen Neptunus Interlong Bio-Technique Co Ltd (Neptunus) manufactures and distributes gene engineering drugs and preventive biological products. The company’s products include recombinant human interferon a-2b injection, used to treat hepatitis and cancers; recombinant human interleukin-2 …
  • Ocean Power Technologies Inc (OPTT):企業の財務・戦略的SWOT分析
    Ocean Power Technologies Inc (OPTT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Lockheed Martin Aeronautics Company:企業の戦略・SWOT・財務分析
    Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Dragon Oil Plc:企業の戦略的SWOT分析
    Dragon Oil Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Provenance Biopharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析
    Summary Provenance Biopharmaceuticals Corp (Provenance) is a biotechnology company that develops various novel immunotherapeutic drugs to treat cancer and other serious, life-threatening diseases. The company offers cancer drugs based on antibodies which include avastin, erbitux, hercepton, and ritu …
  • Day & Zimmermann Group, Inc.:戦略・SWOT・企業財務分析
    Day & Zimmermann Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Day & Zimmermann Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Powerex Inc:企業の戦略的SWOT分析
    Powerex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Oriola-KD Oyj (OKDBV):企業の財務・戦略的SWOT分析
    Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Odfjell Drilling Ltd (ODL):企業の財務・戦略的SWOT分析
    Odfjell Drilling Ltd (ODL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • TOTAL S.A.:戦略・SWOT・企業財務分析
    TOTAL S.A. - Strategy, SWOT and Corporate Finance Report Summary TOTAL S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • E*Trade Financial Corporation:企業のM&A・事業提携・投資動向
    E*Trade Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's E*Trade Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Walchandnagar Industries Ltd:企業の戦略・SWOT・財務分析
    Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sinopec Shanghai Petrochemical Co Ltd (600688):企業の財務・戦略的SWOT分析
    Sinopec Shanghai Petrochemical Co Ltd (600688) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • OpenHydro Group Limited-エネルギー分野:企業M&A・提携分析
    Summary OpenHydro Group Limited (OpenHydro), a subsidiary of DCNS S.A. designs and manufactures marine turbines for generating renewable energy from tidal streams. The company offers installation and maintenance services for the construction of tidal farms using its Open-Centre Turbine technology. T …
  • The Akita Bank Ltd:企業の戦略・SWOT・財務情報
    The Akita Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Akita Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Constantia Flexibles Group GmbH:企業の戦略的SWOT分析
    Constantia Flexibles Group GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆